HK1165275A1 - Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition - Google Patents

Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition

Info

Publication number
HK1165275A1
HK1165275A1 HK12105854.0A HK12105854A HK1165275A1 HK 1165275 A1 HK1165275 A1 HK 1165275A1 HK 12105854 A HK12105854 A HK 12105854A HK 1165275 A1 HK1165275 A1 HK 1165275A1
Authority
HK
Hong Kong
Prior art keywords
prepare
pharmaceutical composition
indazolemethoxyalkanoic
acid
indazolemethoxyalkanoic acid
Prior art date
Application number
HK12105854.0A
Other languages
English (en)
Chinese (zh)
Inventor
Angelo Guglielmotti
Giuseppe Biondi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1165275A1 publication Critical patent/HK1165275A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
HK12105854.0A 2006-11-24 2012-06-15 Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition HK1165275A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002254A ITMI20062254A1 (it) 2006-11-24 2006-11-24 Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Publications (1)

Publication Number Publication Date
HK1165275A1 true HK1165275A1 (en) 2012-10-05

Family

ID=38198404

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09108892.3A HK1129071A1 (en) 2006-11-24 2009-09-25 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
HK12105854.0A HK1165275A1 (en) 2006-11-24 2012-06-15 Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09108892.3A HK1129071A1 (en) 2006-11-24 2009-09-25 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels

Country Status (24)

Country Link
US (2) US8198310B2 (xx)
EP (2) EP2409698B1 (xx)
JP (1) JP5192490B2 (xx)
KR (1) KR101413616B1 (xx)
CN (1) CN101541323B (xx)
AR (1) AR063894A1 (xx)
AU (1) AU2007323351B2 (xx)
BR (1) BRPI0718522A2 (xx)
CA (1) CA2666371C (xx)
CY (1) CY1116664T1 (xx)
DK (2) DK2409698T3 (xx)
EA (1) EA016885B1 (xx)
ES (2) ES2403584T3 (xx)
GE (1) GEP20125570B (xx)
HK (2) HK1129071A1 (xx)
IL (1) IL198286A (xx)
IT (1) ITMI20062254A1 (xx)
MX (1) MX2009004295A (xx)
PL (2) PL2097080T3 (xx)
PT (2) PT2097080E (xx)
SG (1) SG176508A1 (xx)
SI (2) SI2409698T1 (xx)
UA (1) UA97123C2 (xx)
WO (1) WO2008061671A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
MX2012001520A (es) 2009-08-03 2012-06-01 Acraf Proceso para la preparacion de 1-bencil-3-hidroximetil-1h-indazol y sus derivados e intermediarios de magnesio requeridos.
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP6625064B2 (ja) * 2014-05-15 2019-12-25 トランスレイタム メディカス インコーポレイテッド 眼障害を治療かつ診断するための組成物および方法
WO2020261158A1 (en) 2019-06-25 2020-12-30 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1253703B (it) 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
IT1293794B1 (it) 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
CA2819705C (en) * 1998-02-02 2014-07-08 Trustees Of Tufts College Method of regulating glucose metabolism, and reagents related thereto
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US20060030582A1 (en) * 2002-04-29 2006-02-09 Demartino Julie Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
WO2006117316A1 (en) * 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
EP1959982B1 (en) * 2005-12-01 2012-08-08 Flinders Technologies PTY. Ltd. Methods and compositions for preventing and/or treating pancreatitis
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Also Published As

Publication number Publication date
SI2409698T1 (sl) 2015-04-30
WO2008061671A2 (en) 2008-05-29
US8198310B2 (en) 2012-06-12
JP5192490B2 (ja) 2013-05-08
PL2097080T3 (pl) 2013-07-31
PT2097080E (pt) 2013-04-01
EA200970506A1 (ru) 2009-10-30
EP2409698A1 (en) 2012-01-25
US8846745B2 (en) 2014-09-30
EP2409698B1 (en) 2015-01-21
SG176508A1 (en) 2011-12-29
PL2409698T3 (pl) 2015-06-30
CA2666371A1 (en) 2008-05-29
SI2097080T1 (sl) 2013-05-31
PT2409698E (pt) 2015-02-10
DK2097080T3 (da) 2013-05-21
UA97123C2 (uk) 2012-01-10
US20120283307A1 (en) 2012-11-08
US20100069456A1 (en) 2010-03-18
EA016885B1 (ru) 2012-08-30
WO2008061671A3 (en) 2008-11-27
CN101541323A (zh) 2009-09-23
DK2409698T3 (en) 2015-04-27
EP2097080B1 (en) 2013-02-20
AU2007323351A1 (en) 2008-05-29
GEP20125570B (en) 2012-07-10
JP2010510263A (ja) 2010-04-02
IL198286A (en) 2016-03-31
HK1129071A1 (en) 2009-11-20
ES2530623T3 (es) 2015-03-04
CN101541323B (zh) 2012-01-04
CY1116664T1 (el) 2017-03-15
EP2097080A2 (en) 2009-09-09
AU2007323351B2 (en) 2013-05-02
KR20090081410A (ko) 2009-07-28
MX2009004295A (es) 2009-05-05
ITMI20062254A1 (it) 2008-05-25
ES2403584T3 (es) 2013-05-20
CA2666371C (en) 2014-05-06
IL198286A0 (en) 2010-02-17
KR101413616B1 (ko) 2014-07-01
AR063894A1 (es) 2009-02-25
BRPI0718522A2 (pt) 2013-11-12

Similar Documents

Publication Publication Date Title
ZA201808083B (en) Pharmaceutical composition containing a tetrahydrofolic acid
ZA200900028B (en) Improvements relating to pharmaceutical compositions
HK1212157A1 (en) Low dose lipoic acid pharmaceutical compositions and methods
EP2344165A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
ZA200808530B (en) Pharmaceutical composition for external use
IL195541A0 (en) Pharmaceutical compositions of memantine
ZA200808531B (en) Pharmaceutical composition for external use
EP2037872A4 (en) COMPOSITIONS COMPRISING BITULONIC ACID
EP2036565A4 (en) PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN WITH TRITERPENIC ACID
GB0624963D0 (en) Derivatives of 188-Glycyrrhetinic Acid
ZA201106703B (en) Use of pharmaceutical compositions containing mesembrenone
EP2433631A4 (en) ANTI-INFLAMMATORY COMPOSITION CONTAINING MACROLACTIN A AND DERIVATIVE THEREOF AS ACTIVE INGREDIENTS
ZA201107122B (en) Stable pharmaceutical compositions of diclofenac
IL205313A0 (en) Pharmaceutical formulation of clavulanic acid
HK1165275A1 (en) Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition
GB0815852D0 (en) Improvements relating to pharmaceutical compositions
AP2495A (en) Use of gamma-aminobutyric acid as a depigmentationagent
EP2114374A4 (en) PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE
IL213711A (en) Nano-phenofibrate preparation
ZA201101053B (en) Pharmaceutical compositions of samatotrophic hormones
IL198835A0 (en) Pharmaceutical compositions of memantine
HK1162935A1 (en) Pharmaceutical composition comprising a prostaglandin
PL2195006T3 (pl) Zastosowanie analogu bifaliny jako przeciwbólowego środka farmaceutycznego
ZA200806439B (en) Stable dosage formulations of imidazolylalkyl-pyridines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181112